SCHEDULE 13D: Thalassa Holdings and Duncan Soukup Disclose 5.21% Stake in Encision Inc.
Beneficial Ownership Disclosure
Thalassa Holdings, Ltd. and its Executive Chairman, Duncan Soukup, have jointly disclosed a beneficial ownership of 5.21% in Encision Inc., holding 619,272 shares for investment purposes.
Summary
- Thalassa Holdings, Ltd. and Duncan Soukup have filed a Schedule 13D, reporting a joint beneficial ownership of 619,272 shares of Encision Inc. Common Stock.
- This stake represents 5.21% of Encision Inc.'s outstanding shares, based on 11,879,645 shares outstanding as of December 31, 2024.
- The shares were acquired using working capital funds by Thalassa Holdings, Ltd.
- The Reporting Persons state their purpose for holding the Common Stock is for investment.
- They may, from time to time, acquire additional shares, retain, or sell their holdings based on market conditions, Encision's performance, and alternative investment opportunities.
- Recent open market purchases by Thalassa Holdings, Ltd. include 5,000 shares at $0.45 on February 18, 2025; 21,500 shares at GBP 0.4329 on February 19, 2025; and 322 shares at $0.43 on February 28, 2025.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. A new significant investor can be seen as a positive signal, but the document itself is a regulatory disclosure without specific positive or negative news about the issuer's operations or financials. The 'investment purposes' statement is neutral.
Positives
- A new significant investor, Thalassa Holdings, Ltd., and its Executive Chairman, Duncan Soukup, have taken a 5.21% stake in Encision Inc., potentially signaling confidence in the company.
- The acquisition was for "investment purposes," suggesting a long-term view rather than immediate activist intent.
Risks
- The Reporting Persons may acquire additional shares, retain, or sell all or a portion of their holdings, which could impact the stock price depending on their actions.
- Future actions of the Reporting Persons are dependent on various factors including price levels, market conditions, Encision's business performance, and alternative investment opportunities, introducing uncertainty.
Future Outlook
The Reporting Persons hold the Common Stock for investment purposes and may, from time to time, acquire additional shares, retain, or sell all or a portion of their holdings. Their future actions will depend on factors such as the Common Stock's price levels, general market and economic conditions, ongoing evaluation of Encision Inc.'s business, financial condition, operations, and prospects, the attractiveness of alternative investment opportunities, and liquidity needs.
Industry Context
This filing indicates a new significant shareholder in Encision Inc. Such filings can sometimes precede activist campaigns or strategic shifts, but this one explicitly states "investment purposes" and no present plans for changes, suggesting a passive investment for now.
Stakeholder Impact
- Shareholders: The entry of a new significant shareholder could influence market perception and potentially the stock price. Future actions of this shareholder (buying/selling) will directly impact other shareholders.
Next Steps
- The Reporting Persons may acquire additional shares of Encision Inc. Common Stock.
- The Reporting Persons may retain or sell all or a portion of their currently held shares.
- Future actions will be dependent on various factors including market conditions and Encision Inc.'s performance.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Date as of which 11,879,645 shares of Encision Inc. Common Stock were outstanding, used for percentage calculation. |
| 2025-02-14 | Date Encision Inc.'s Quarterly Report on Form 10-Q for the quarter ended December 31, 2024, was filed with the SEC. |
| 2025-02-18 | Date of event which required the filing of this statement; also a transaction date for 5,000 shares at $0.45. |
| 2025-02-19 | Transaction date for 21,500 shares at GBP 0.4329. |
| 2025-02-28 | Transaction date for 322 shares at $0.43. |
| 2025-03-07 | Date of signing and filing of the Schedule 13D and the Joint Filing Agreement. |
Keywords
Encision Inc., Thalassa Holdings, Duncan Soukup, Schedule 13D, Beneficial Ownership, Common Stock, Investment, SEC Filing, Shareholder, Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.